Ontrak Testcard 9
Enzyme Immunoassay, Amphetamine. 510(k) K012396, from Roche Diagnostics Corp. (Indianapolis, IN). Product code DKZ, class 2.
As of Nov 20, 2026, K012396 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Nov 5, 2001 after 101 days, with no recalls tied to it in FDA's recall database.
- Review time: 101 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Roche Diagnostics Corporation OnTrak TesTcard 9 is an in vitro diagnostic test intended for use by health care professionals only for the qualitative detection of drug or drug metabolites in urine. OnTrak TesTcard 9 simultaneously tests for the presence of multiple drugs or drug metabolites.
- Triage Panel for Drugs of Abuse, Plus Tricyclic Antidepressants and Other Triage Drug TestsK973784 · Biosite Incorporated · Dec 3, 1997
- Ontrak Teststik for Methamphetamine, Cat. 1986686K000096 · Roche Diagnostics Corp. · Apr 26, 2000
- On Trak TestcardK051235 · Varian, Inc. · Jun 8, 2005
- DRI Ecstasy Plus AssayK240670 · Microgenics Corporation · Oct 30, 2024
- AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest…K233019 · Hangzhou AllTest Biotech Co., Ltd. · Dec 13, 2023
- Xenta Drug Screen Cup, Xenta Drug Screen DipcardK231137 · Xenta Biomedical Science Co., Ltd. · May 19, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Abbreviated
- Received
- Jul 27, 2001
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files